BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Activity

234 hedge funds and large institutions have $1.87B invested in BioCryst Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 76 increasing their positions, 59 reducing their positions, and 26 closing their positions.

Holders
234
Holders Change
+13
Holders Change %
+5.88%
% of All Funds
4.05%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
42
Increased
76
Reduced
59
Closed
26
Calls
$54.3M
Puts
$18M
Net Calls
+$36.2M
Net Calls Change
+$11.7M

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$114M
2
GKIM
2
GW&K Investment Management
Massachusetts
$17.9M
3
Two Sigma Investments
3
Two Sigma Investments
New York
$13M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$71.9M
5
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$6.24M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$11.5M
2
State Street
2
State Street
Massachusetts
$118M
3
PAMS
3
Pictet Asset Management (Switzerland)
Switzerland
$60.7M
4
Victory Capital Management
4
Victory Capital Management
Texas
$44.4M
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SOW
251
State of Wyoming
Wyoming
– -$11K -1,082 Closed
TCWM
252
Total Clarity Wealth Management
Illinois
– -$4K -400 Closed
HR
253
Howe & Rusling
New York
– -$1K -100 Closed
EI
254
Ellevest Inc
New York
– -$1K -96 Closed
7 8 9 10
11